NewBridge Pharmaceuticals (“NewBridge” or “the Company”) announce that they have entered a distribution agreement with Biogen International GmbH (Biogen) for the distribution and commercialization of certain Biogen Multiple Sclerosis products in selected countries in the Middle East and North Africa (“MENA”).
This website uses cookies to collect information in connection with your use of this website. By continuing to use this website, you agree to the use of all our cookies, which includes new versus returning visitors and country location only. We do not collect personal information. Privacy Notice & Terms and Conditions